Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion

Prostate

Volumn 75, Issue 6, 2015, Pages 561-572

  Gang, Xiaokun ^a,b   Wang, Guixia ^a   Huang, Haojie ^b,c,d  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b MAYO CLINIC   (United States)

^c DEPARTMENT OF UROLOGY   (United States)

^d MAYO CLINIC CANCER CENTER   (United States)

Author keywords

Androgen; AR; invasion; metastasis; prostate cancer; SMURF1

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; MESSENGER RNA; SMAD UBIQUITINATION REGULATORY FACTOR 1 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; MIBOLERONE; NANDROLONE; SMURF1 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL INVASION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ELECTROPORATION; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LNCAP CELL LINE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DNA BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NANDROLONE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 84925444869     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22935     Document Type: Article

References (22)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB, Jr., Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Flechon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI,. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011; 364: 1995-2005.
3. Attard G, Belldegrun AS, de Bono JS,. Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer. BJU Int 2005; 96: 1241-1246.
4. David D, Nair SA, Pillai MR,. Smurf E3 ubiquitin ligases at the cross roads of oncogenesis and tumor suppression. Biochim Biophys Acta 2013; 1835: 119-128.
5. Wang HR, Ogunjimi AA, Zhang Y, Ozdamar B, Bose R, Wrana JL,. Degradation of RhoA by Smurf1 ubiquitin ligase. Methods Enzymol 2006; 406: 437-447.
6. Tian M, Bai C, Lin Q, Lin H, Liu M, Ding F, Wang HR,. Binding of RhoA by the C2 domain of E3 ligase Smurf1 is essential for Smurf1-regulated RhoA ubiquitination and cell protrusive activity. FEBS Lett 2011; 585: 2199-2204.
7. Yamaguchi K, Ohara O, Ando A, Nagase T,. Smurf1 directly targets hPEM-2, a GEF for Cdc42, via a novel combination of protein interaction modules in the ubiquitin-proteasome pathway. Biol Chem 2008; 389: 405-413.
8. Huang H, Cheville JC, Pan Y, Roche PC, Schmidt LJ, Tindall DJ,. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J Biol Chem 2001; 276: 38830-38836.
9. Wang L, Zeng X, Chen S, Ding L, Zhong J, Zhao JC, Sarver A, Koller A, Zhi J, Ma Y, Yu J, Chen J, Huang H,. BRCA1 is a negative modulator of the PRC2 complex. Embo J 2013; 32: 1584-1597.
10. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K,. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129: 823-837.
11. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B,. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39: 311-318.
12. Sanchez NS, Barnett JV,. TGFbeta and BMP-2 regulate epicardial cell invasion via TGFbetaR3 activation of the Par6/Smurf1/RhoA pathway. Cell Signal 2012; 24: 539-548.
13. Kwon A, Lee HL, Woo KM, Ryoo HM, Baek JH,. SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion. Mol Cells 2013; 36: 548-555.
14. Hara T, Miyazaki H, Lee A, Tran CP, Reiter RE,. Androgen receptor and invasion in prostate cancer. Cancer Res 2008; 68: 1128-1135.
15. Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, Thalmann GN, Cecchini MG, Pienta KJ, Chung LW,. Cellular interactions in the tropism of prostate cancer to bone. Int J Cancer 2004; 110: 497-503.
16. Bennett ES, Smith BA, Harper JM,. Voltage-gated Na+ channels confer invasive properties on human prostate cancer cells. Pflugers Arch 2004; 447: 908-914.
17. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH,. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 1999; 400: 687-693.
18. Izzi L, Attisano L,. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation. Oncogene 2004; 23: 2071-2078.
19. Wang W, Ren F, Wu Q, Jiang D, Li H, Peng Z, Wang J, Shi H,. MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1. Biochem Biophys Res Commun 2014; 449: 432-437.
20. Allioli N, Vincent S, Vlaeminck-Guillem V, Decaussin-Petrucci M, Ragage F, Ruffion A, Samarut J,. TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration. Prostate 2011; 71: 1239-1250.
21. Sekine Y, Demosky SJ, Stonik JA, Furuya Y, Koike H, Suzuki K, Remaley AT,. High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. Mol Cancer Res 2010; 8: 1284-1294.
22. Wang D, Garcia-Bassets I, Benner C, Li W, Su X, Zhou Y, Qiu J, Liu W, Kaikkonen MU, Ohgi KA, Glass CK, Rosenfeld MG, Fu XD,. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011; 474: 390-394.